Not Yet RecruitingNot Applicable

Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia

120 participantsStarted 2024-12-01

Plain-language summary

This study aims to test the hypothesis that addition of Individual Placement and Support (IPS) and/or Cognitive Remediation Therapy (CRT) in addition to treatment as usual in patients with early psychosis will be feasible and acceptable in patients with early schizophrenia.

Who can participate

Age range18 Years – 35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male/Female patients aged between 18-35 years.
✓. Diagnosis of schizophrenia confirmed by SCID meeting DSM-V criteria for schizophrenia, schizophreniform or schizoaffective psychosis.
✓. Stable on medication for the past four weeks.
✓. In contact with mental health services
✓. Within 5 years of diagnosis.
✓. Able to demonstrate the capacity to provide informed consent to take part in this feasibility trial, as assessed by their own clinician.

Exclusion criteria

✕. Active DSM-V substance abuse (except nicotine or caffeine) or dependence within the last three months
✕. Relevant CNS or other medical disorders
✕. Diagnosis of Learning Disability.

What they're measuring

Feasibility of undertaking a trial of the intervention, as determined by: Recruitment and attrition rates

Timeframe: 6 month post intervention

Acceptability of the intervention, as determined by: number of sessions attended

Timeframe: 6 months post intervention

Client Satisfaction Questionnaire (CSQ)

Timeframe: 6 month post intervention

Trial details

NCT IDNCT03974620

SponsorPakistan Institute of Living and Learning

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-30

View on ClinicalTrials.gov More Schizophrenia trials